- Home
- BNR vs PIII Comparison
BNR vs PIII Comparison
Compare BNR & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- PIII
- Stock Information
- Founded
- BNR 2014
- PIII 2015
- Country
- BNR China
- PIII United States
- Employees
- BNR N/A
- PIII N/A
- Industry
- BNR Medical Specialities
- PIII Medical/Nursing Services
- Sector
- BNR Health Care
- PIII Health Care
- Exchange
- BNR Nasdaq
- PIII Nasdaq
- Market Cap
- BNR 28.6M
- PIII 33.2M
- IPO Year
- BNR 2020
- PIII N/A
- Fundamental
- Price
- BNR $5.38
- PIII $0.22
- Analyst Decision
- BNR
- PIII Buy
- Analyst Count
- BNR 0
- PIII 3
- Target Price
- BNR N/A
- PIII $2.38
- AVG Volume (30 Days)
- BNR 20.0K
- PIII 715.2K
- Earning Date
- BNR 11-29-2024
- PIII 11-12-2024
- Dividend Yield
- BNR N/A
- PIII N/A
- EPS Growth
- BNR N/A
- PIII N/A
- EPS
- BNR N/A
- PIII N/A
- Revenue
- BNR $70,154,674.00
- PIII $1,476,630,000.00
- Revenue This Year
- BNR $52.90
- PIII $22.79
- Revenue Next Year
- BNR $48.35
- PIII $14.15
- P/E Ratio
- BNR N/A
- PIII N/A
- Revenue Growth
- BNR N/A
- PIII 25.38
- 52 Week Low
- BNR $2.62
- PIII $0.19
- 52 Week High
- BNR $9.99
- PIII $1.78
- Technical
- Relative Strength Index (RSI)
- BNR 80.41
- PIII 28.78
- Support Level
- BNR $4.55
- PIII $0.19
- Resistance Level
- BNR $3.89
- PIII $0.25
- Average True Range (ATR)
- BNR 0.42
- PIII 0.04
- MACD
- BNR 0.23
- PIII -0.02
- Stochastic Oscillator
- BNR 99.26
- PIII 9.02
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.